P172: A framework to identify individuals at low risk of disease in the population*

Genetics can be used to identify individuals at lower risk of disease. Benefits include (i) reallocating resources to those at increased risk, (ii) avoiding unnecessary screening, and (iii) facilitating discussions with the ‘average’ risk group about the importance of following the standard guidelines. However, few papers focus on the genetics of resistance to disease, and genetic screening programs currently do not return results for low disease risk. Concerns about misclassifying individuals at low risk have hindered implementing a ‘low genetic risk’ program.

Authors

Institutions

Publication Details

Journal
Genetics in Medicine Open
Published
2025-01-01
DOI
https://doi.org/10.1016/j.gimo.2025.102137
Primary Topic
Chronic Disease Management Strategies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

P172: A framework to identify individuals at low risk of disease in the population*

Natalie Telis, Christopher Chapman, Douglas Stoller, Kelly M. Schiabor Barrett et al.
Genetics in Medicine Open
Chronic Disease Management Strategies
article

P172: A framework to identify individuals at low risk of disease in the population*

Natalie Telis, Christopher Chapman, Douglas Stoller, Kelly M. Schiabor Barrett, Alexandre Bolze, Matthew E. Levy, Joseph J. Grzymski, Daniel Philip Judge, C. Anwar A. Chahal, Elizabeth T. Cirulli, Cassie Hajek, William Lee, Douglas A. Olson, Jeremy Cauwels
article en

Abstract

Genetics can be used to identify individuals at lower risk of disease. Benefits include (i) reallocating resources to those at increased risk, (ii) avoiding unnecessary screening, and (iii) facilitating discussions with the ‘average’ risk group about the importance of following the standard guidelines. However, few papers focus on the genetics of resistance to disease, and genetic screening programs currently do not return results for low disease risk. Concerns about misclassifying individuals at low risk have hindered implementing a ‘low genetic risk’ program.

Genetics in Medicine OpenVol. 3
St. Luke's University Health Network (US), Sanford Health (US), University of Nevada, Reno (US), Medical University of South Carolina (US), WellSpan Health (US), WellSpan Ephrata Community Hospital (US), Helix (United States) (US), HealthPartners (US), University of Nebraska Medical Center (US)
Openalex Percentile: Top 92%
Chronic Disease Management Strategies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.